{
  "zip": "94608",
  "sector": "Healthcare",
  "fullTimeEmployees": 4,
  "longBusinessSummary": "Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.",
  "city": "Emeryville",
  "phone": "510-595-6000",
  "state": "CA",
  "country": "United States",
  "companyOfficers": [],
  "maxAge": 1,
  "address1": "2000 Powell Street",
  "fax": "510-595-6006",
  "industry": "Biotechnology",
  "address2": "Suite 800",
  "previousClose": 0.0025,
  "regularMarketOpen": 0.0048,
  "twoHundredDayAverage": 0.003879058,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.0048,
  "navPrice": null,
  "averageDailyVolume10Day": 6012,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.0025,
  "fiftyDayAverage": 0.0026772728,
  "trailingAnnualDividendRate": null,
  "open": 0.0048,
  "averageVolume10days": 6012,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.304096,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.0048,
  "priceHint": 4,
  "currency": "USD",
  "trailingPE": 0.0069666184,
  "regularMarketVolume": 3000,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 10427472,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 42885,
  "priceToSalesTrailing12Months": 0.41182747,
  "dayLow": 0.0048,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 3000,
  "fiftyTwoWeekHigh": 0.018,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0002,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.0048,
  "exchange": "PNK",
  "shortName": "NEUROBIOLOGICAL TECHNOLOGIES IN",
  "longName": "Neurobiological Technologies, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "NTII",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_330307",
  "uuid": "d50edd4c-7b6d-3a1d-9820-99964ac9553f",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": -1.034,
  "beta3Year": null,
  "profitMargins": 0.7372,
  "enterpriseToEbitda": -1.34,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 27019800,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 1.072,
  "sharesShort": 37597,
  "sharesPercentSharesOut": 0.0014,
  "fundFamily": null,
  "lastFiscalYearEnd": 1246320000,
  "heldPercentInstitutions": 0.09418,
  "netIncomeToCommon": 18666000,
  "trailingEps": 0.689,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 0.004477612,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1309392000,
  "mostRecentQuarter": 1261008000,
  "shortRatio": 0.09,
  "sharesShortPreviousMonthDate": 1258070400,
  "floatShares": null,
  "enterpriseValue": -26174450,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1189987200,
  "lastSplitFactor": "1:7",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1260835200,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": 0.0034,
  "sharesShortPriorMonth": 2317,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.0048,
  "logo_url": ""
}